NIH, National Cancer Institute, Division of Cancer Treatment and Diagnosis (DCTD) NIH - National Institutes of Health National Cancer Institute DCTD - Division of Cancer Treatment and Diagnosis

Primary hemostatic capacity of whole blood: a comprehensive analysis of pathogen reduction and refrigeration effects over time.

Author(s): Pidcoke HF, McFaul SJ, Ramasubramanian AK, Parida BK, Mora AG, Fedyk CG, Valdez-Delgado KK, Montgomery RK, Reddoch KM, Rodriguez AC, Aden JK, Jones JA, Bryant RS, Scherer MR, Reddy HL, Goodrich RP, Cap AP

Publication: Transfusion, 2013, Vol. 53 Suppl 1, Page 137S-149S

PubMed ID: 23301966 PubMed Review Paper? No

Purpose of Paper

The purpose of this paper was to determine the effects of storage temperature and pathogen reduction technology (PRT) treatment on markers of blood quality.

Conclusion of Paper

During storage, lactate, prothrombin time (PT), activated partial thromboplastin time (aPTT), and hemolysis increased, and granulocyte counts, platelet (plt) counts, glucose, pH, factor V, factor VIII, protein C, antithrombin III, glycoprotein Ib alpha (GPIb) expressing plt population, and agonist-stimulated and unstimulated plt aggregation decreased, while thromboelastography (TEG) parameters and fibrinolysis were significantly altered. The changes in lactate, glucose, granulocyte counts, PT, pH, TEG parameters, fibrinolysis, protein C, factor VIII, antithrombin III, GPIb expressing plt population, and agonist-stimulated and unstimulated plt aggregation were larger in specimens stored at room temperature compared to those that were refrigerated. The storage induced changes in glucose, fibrinolysis, and, in some cases, agonist stimulated platelet aggregation, were significantly attenuated by PRT treatment, but the changes in granulocyte count, PT, aPTT, factor V, factor VIII and some TEG parameters were larger in PRT-treated specimens than untreated specimens. Hematocrit (Hct), hemoglobin (Hb), D-dimer, red blood cell (RBC) counts, fibrinogen, von Willebrand factor, most microparticle (MP) subpopulations and soluble CD40 ligand were not significantly affected by storage duration or temperature.

Studies

  1. Study Purpose

    The purpose of this study was to determine the effects of storage duration and temperature and PRT-treatment on markers of blood quality. Blood was collected in citrate-phosphate-dextrose (CPD), and half of the specimens were PRT treated in illumination bags by addition of riboflavin and exposure to ultraviolet (UV) light. Specimens were then transferred to storage bags, kept in metal lined storage containers at each temperature, and sampled aseptically.

    Summary of Findings:

    Lactate increased and glucose and pH decreased with storage, and changes were larger at 22 degrees C compared to at 4 degrees C (p<0.0001, p<0.0001, and p<0.001, respectively). Only the changes in glucose were significantly attenuated by PRT treatment (p<0.008). Hemolysis was unaffected by refrigerated storage but increased during storage at room temperature, especially at day 7 (p=0.014) and beyond. Plt counts decreased with storage at 4 degrees C and PRT treatment. Granulocytes decreased with storage, particularly at room temperature, or with PRT treatment. Clinically irrelevant but statistically significant decreases in white blood cell (WBC) counts were observed during storage, especially in PRT treated specimens. Hct, Hb, RBC counts, D-dimer and soluble CD40 ligand were not significantly affected by storage. PT and aPTT increased with storage duration, but the increase in PT was attenuated by refrigeration, and PT and aPTT were higher in PRT treated specimens than untreated specimens. Agonist stimulated plt aggregation decreased with storage (p<0.001), but the decrease was attenuated by refrigeration. PRT treatment attenuated the storage induced decreases in collagen, thrombin receptor-activating peptide-6, and low ristocetin (RL)-stimulated aggregation compared with untreated specimens (p=0.033) but did not affect adenosine diphosphate (ADP), arachidonic acid agonist (ASPI), and high ristocetin-stimulated aggregation. TEG clotting time (R), clot formation (K), maximum amplitude (MA), clot strength, and total thrombin generation (TTG) were affected by storage at room temperature but remained relatively stable during storage at 4 degrees C. Changes in TEG R, K, alpha angle, and MA during storage were greater in PRT treated specimens then untreated specimens. Fibrinolysis was affected by storage at room temperature, but changes were attenuated by refrigeration (p=0.012) or PRT-treatment (p<0.001).

    Biospecimens
    Preservative Types
    • None (Fresh)
    Diagnoses:
    • Normal
    Platform:
    AnalyteTechnology Platform
    Cell count/volume Hematology/ auto analyzer
    Cell count/volume Flow cytometry
    Morphology Hematology/ auto analyzer
    Protein Hematology/ auto analyzer
    Protein ELISA
    Glycoprotein Hematology/ auto analyzer
    Peptide Hematology/ auto analyzer
    Carbohydrate Clinical chemistry/auto analyzer
    Small molecule Clinical chemistry/auto analyzer
    Pre-analytical Factors:
    ClassificationPre-analytical FactorValue(s)
    Storage Storage duration 0 days
    1 day
    2 days
    3 days
    4 days
    5 days
    6 days
    7 days
    14 days
    21 days
    Storage Storage temperature 4 degrees C
    22 degrees C
    Storage Storage conditions PRT-treated
    Untreated
    Hematology/ auto analyzer Specific Reaction solution Collagen
    TRAP-6
    Low ristocetin
    High ristocetin
    ADP
    Arachidonic acid
    Biospecimen Aliquots and Components Blood processing method PRT treated
    Untreated
  2. Study Purpose

    The purpose of this study was to determine the effects of storage temperature and PRT-treatment on coagulation markers in plasma. Blood was collected in CPD, and half of the specimens were PRT treated in illumination bags by the addition of riboflavin and exposure to UV light. Specimens were then transferred to storage bags which were stored in metal lined storage containers at each temperature and sampled aseptically.

    Summary of Findings:

    Factor V, VIII, and protein C in plasma decreased with storage of whole blood (p<0.001). Larger decreases in Factor V and VIII levels were noted in PRT-treated specimens than untreated specimens (p<0.001, both), and larger decreases in protein C and factor VIII were observed with storage of blood at room temperature than 4 degrees C (p<0.001 and p=0.036, respectively). Fibrinogen decreased initially in PRT treated specimens (p<0.001), but storage did not have a significant effect, and all levels were within the normal range. Antithrombin III decreased with storage of blood at room temperature (p<0.001), with insignificantly larger changes noted in PRT treated specimens than untreated specimens. von Willebrand factor levels were not affected by PRT-treatment or storage of blood specimens.

    Biospecimens
    Preservative Types
    • None (Fresh)
    Diagnoses:
    • Normal
    Platform:
    AnalyteTechnology Platform
    Protein Hematology/ auto analyzer
    Glycoprotein Hematology/ auto analyzer
    Pre-analytical Factors:
    ClassificationPre-analytical FactorValue(s)
    Storage Storage duration 0 days
    7 days
    14 days
    Storage Storage temperature 4 degrees C
    22 degrees C
    Storage Storage conditions PRT-treated
    Untreated
    Biospecimen Aliquots and Components Blood processing method PRT treated
    Untreated
    Biospecimen Aliquots and Components Centrifugation Centrifugation delays investigated
  3. Study Purpose

    The purpose of this study was to determine the effects of storage temperature and PRT-treatment on plt aggregation and MP counts. Blood was collected CPD, and half of the specimens were PRT treated in illumination bags by the addition of riboflavin and exposure to UV light. Specimens were then transferred to storage bags which were stored in metal lined storage containers at each temperature and sampled aseptically.

    Summary of Findings:

    Measures of plt aggregation, including percent surface coverage (%SC) and aggregate size (AS), decreased with storage of blood. The decreases were attenuated by refrigeration (p<0.001 and p<0.019) but not PRT-treatment, and %SC and AS remained within the normal range during storage, regardless of conditions. Further, shear-induced plt aggregation (SIPA) and ristocetin-induced plt agglutination (RIPA) were higher after refrigerated storage of blood specimens for 7 days than after room temperature storage (p=0.032 and p=0.002, respectively). The glycoprotein Ib alpha (GPIb) expressing plt population and mean fluorescent intensity of staining decreased with storage, with greater declines noted at room temperature than 4 degrees C (p<0.001 and p=0.004 at day 7, respectively). MP subpopulations tended to increase with storage, but overall increases were insignificant. However, the increases in PRT treated and untreated RBC-MP counts and untreated WBC-MP and tissue factor (TF)-MP counts were significantly greater when blood was stored at room temperature rather than 4 degrees C.

    Biospecimens
    Preservative Types
    • None (Fresh)
    Diagnoses:
    • Normal
    Platform:
    AnalyteTechnology Platform
    Cell count/volume Flow cytometry
    Protein Hematology/ auto analyzer
    Morphology Hematology/ auto analyzer
    Pre-analytical Factors:
    ClassificationPre-analytical FactorValue(s)
    Storage Storage conditions PRT-treated
    Untreated
    Storage Storage duration 0 days
    1 days
    2 days
    3 days
    4 days
    5 days
    6 days
    7 days
    10 days
    14 days
    21 days
    Storage Storage temperature 4 degrees C
    22 degrees C
    Biospecimen Aliquots and Components Blood processing method PRT treated
    Untreated

You Recently Viewed  

News and Announcements

  • Most Downloaded SOPs in 2024

  • New Articles on the GTEx Project are Now FREELY Available!

  • Just Published!

  • More...